Literature DB >> 22187059

Decreased vitamin D levels in patients with familial mediterranean fever.

Bunyamin Kisacik1, Suheyla Uzun Kaya, Yavuz Pehlivan, Turker Tasliyurt, Mehmet Sayarlioglu, Ahmet Mesut Onat.   

Abstract

Familial mediterranean fever (FMF) is an autosomal recessive disorder caused by mutations in the FMF gene (MEFV). The gene causing FMF, designated MEFV, encodes a protein called pyrin or marenostrin that is expressed mainly in myeloid bone marrow precursors, neutrophils, and monocytes. Since there are several etiological factors, FMF is the most common periodic fever syndrome. However, it is still unknown what triggers or ends these periodical attacks. As a pleiotropic hormone, vitamin D has immunomodulation effects. The aim of this study was to evaluate the vitamin D levels in FMF patients. The study group was comprised of 26 patients diagnosed with FMF (men/women: 12/14), and 34 healthy control (men/women: 17/17). Vitamin D levels in FMF patients and healthy controls were 11.05 ± 7.11, 17.15 ± 6.49, respectively. FMF patients had significantly decreased vitamin D levels compared with healthy controls (P < 0.001). In conclusion, it is thought that vitamin D deficiency in FMF patients may trigger the attacks. Further studies with larger patient populations need to hold to investigate the vitamin D deficiency in patients with FMF and that may assist to clarify the mechanism behind the colchicines resistant cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187059     DOI: 10.1007/s00296-011-2278-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  19 in total

1.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4.

Authors:  M T Cantorna; W D Woodward; C E Hayes; H F DeLuca
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

Review 2.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

3.  1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease.

Authors:  M T Cantorna; C Munsick; C Bemiss; B D Mahon
Journal:  J Nutr       Date:  2000-11       Impact factor: 4.798

4.  Interferon-gamma levels in familial Mediterranean fever.

Authors:  Seyfettin Köklü; Mehmet Akif Oztürk; Mustafa Balci; Osman Yüksel; Ihsan Ertenli; Sedat Kiraz
Journal:  Joint Bone Spine       Date:  2005-01       Impact factor: 4.929

5.  Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3).

Authors:  F Mattner; S Smiroldo; F Galbiati; M Muller; P Di Lucia; P L Poliani; G Martino; P Panina-Bordignon; L Adorini
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

6.  1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro.

Authors:  A Berer; J Stöckl; O Majdic; T Wagner; M Kollars; K Lechner; K Geissler; L Oehler
Journal:  Exp Hematol       Date:  2000-05       Impact factor: 3.084

7.  1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  J Nutr       Date:  1998-01       Impact factor: 4.798

8.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

9.  Th1 polarization in familial Mediterranean fever.

Authors:  Ebru Aypar; Seza Ozen; Homza Okur; Tezer Kutluk; Nesrin Besbas; Aysin Bakkaloglu
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

10.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells.

Authors:  Brett D Mahon; Anja Wittke; Veronika Weaver; Margherita T Cantorna
Journal:  J Cell Biochem       Date:  2003-08-01       Impact factor: 4.429

View more
  6 in total

1.  Decreased serum vitamin B12 and vitamin D levels affect sleep quality in children with familial Mediterranean fever.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balci; Mahir Serbes; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Rheumatol Int       Date:  2017-11-15       Impact factor: 2.631

2.  Vitamin D status, serum lipid concentrations, and vitamin D receptor (VDR) gene polymorphisms in Familial Mediterranean fever.

Authors:  Turan Turhan; Halef Okan Doğan; Nihal Boğdaycioğlu; Nilnur Eyerci; Ahmet Omma; İsmail Sari; Ahmet Yeşilyurt; Yaşar Karaaslan
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

3.  The association between vitamin D levels and oxidative stress markers in Egyptian Behcet's disease patients.

Authors:  Heba S Omar; Fatma Mohamed Taha; Suzanne Fouad; Fatma A Ibrahim; Aliaa El Gendy; Iman H Bassyouni; Reem El-Shazly
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

4.  Serum bone markers levels and bone mineral density in familial mediterranean Fever.

Authors:  Teoman Aydın; Ozgur Taspınar; Yildiz Akbal; Celaleddin Peru; Mustafa Guler; Omer Uysal; M Cengiz Yakıcıer
Journal:  J Phys Ther Sci       Date:  2014-09-17

5.  Vitamin D levels in children with familial Mediterranean fever.

Authors:  Hatice Onur; Hale Aral; Vefik Arica; Gamze Atalay Bercem; Ozgur Kasapcopur
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-27       Impact factor: 3.054

6.  The relation of novel cardiovascular risk parameters in patients with familial Mediterranean fever.

Authors:  Mustafa Kozan; Zeynep Tugba Ozan; Vahit Demir; Hüseyin Ede
Journal:  JRSM Cardiovasc Dis       Date:  2019-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.